SCIENCE · AI-ASSISTED SUMMARY
Stanford AI Discovers Natural Molecule That Cuts Appetite by 50% in Animals
WHY IT MATTERS
BRP offers a promising obesity treatment that may avoid the digestive side effects and muscle loss seen with current drugs, potentially improving patient adherence and outcomes.
What happened
Stanford scientists, using artificial intelligence, identified a natural compound—BRP—that cuts food intake by up to half in laboratory animals. The molecule also accelerates fat loss while sparing muscle tissue. Unlike the current drug Ozempic, BRP does not trigger the digestive upset that often limits patient adherence.
It works through a distinct neural circuit, offering a more targeted approach to appetite control. The discovery was made by training machine‑learning models on thousands of natural products, then testing the top candidates in mice.
Early data show a 50% reduction in daily consumption and a measurable decrease in body fat after a short treatment period. The research team plans to advance the compound into preclinical safety studies next year, aiming to evaluate its pharmacokinetics and potential side‑effect profile before initiating human trials.
LINKED SOURCES
AI helps Stanford scientists discover a “natural Ozempic” with a surprising advantage
ScienceDaily · Discovery only; verify against the cited research or institution when available
THELAST.NEWS is published by Dmitry Yakushev, Cyprus. Briefs are prepared with the help of AI from linked sources and are not individually reviewed by a human editor unless marked otherwise.